Echocardiography of the young athlete: Where are the limits? 24 èmes Journées Européennes de la Société Française de cardiologie janvier 2014

Similar documents
Hypertrophic Cardiomyopathy or «Athlete s Heart»

L essentiel de 2013 Exercice Readaptation et Sport (GERS) Dr Marie Christine Iliou

What is controversial in diagnostic imaging?

Paradoxical low flow-low gradient severe aortic stenosis: where are we?

Mitral valve apparatus in Hypertrophic Cardiomyopathy: a specific assessment?

P. Messner Pellenc, C. Robert

Insuffisance mitrale

Echographic tricky aspects in the athlete's heart

Cardiac Rehabilitation and Electromyostimulation

MYOCARDITIS AND BIOMARKERS. Dr C. Guenancia Service de Cardiologie CHU Dijon

Novel echocardiographic modalities: 3D echo, speckle tracking and strain rate imaging. Potential roles in sports cardiology. Stefano Caselli, MD, PhD

Right ventricular adaptation in endurance athletes. António Freitas. No conflict of interest

Continuous and noninvasive arterial blood pressure monitoring

Left Ventricular Assist Device and Exercise

«Which stent for which coarctation based on mechanical properties?» Modelisation

Nancy Goldman Cutler, MD Beaumont Children s Hospital Royal Oak, Mi

The Athlete s Heart. Critical Role of Echo. Neil J. Weissman, MD MedStar Health Research Institute & Professor of Medicine Georgetown University

Return to Work (RTW) after Acute Coronary Syndrom (ACS) SFC

Cardiac hypertrophy : differentiating disease from athlete

Cancer Associated Thrombosis Approach to VTE recurrence

27-year-old professionnal rugby player: asymptomatic

Athlete s Heart vs. Cardiomyopathy

Introduction. Abbreviations and Definitions

Athlete s Heart vs. Cardiomyopathy

Highlights from EuroEcho 2009 Echo in cardiomyopathies

Professor Sanjay Sharma St George s University of London

Echo Evaluation of the Heart of an Athlete

The Athletic Heart Takes Shape: Overview of Cardiac Remodeling Rory B. Weiner, MD

SABIHA GATI AND SANJAY SHARMA

Prevalence of Modified ARVC Task Force Criteria in Elite Male Athletes

R egular intensive physical exercise is associated with an

LV FUNCTION ASSESSMENT: WHAT IS BEYOND EJECTION FRACTION

The Athlete s Heart. Role of Echo. Neil J. Weissman, MD MedStar Health Research Institute & Professor of Medicine Georgetown University

Dr Navin Chandra Clinical Research Fellow in Cardiology St George s University of London

CARDIAC BENEFICIAL EFFECTS AND ADAPTATIONS IN ATHLETES

CLINICAL RESEARCH ON CARDIOVASCULAR ALTERATION ON 86 S PROFESSIONAL ATHLETES IN IRAN

Athlete s Heart: Clinical Relevance. Athlete's Heart vs. Cardiac Pathology Clinical Approaches. Echo Florida Conflicts of Interest: None

Echocardiographie de la Tétralogie de Fallot opérée

Hypertensive heart disease and failure

Evaluation of Left Ventricular Diastolic Dysfunction by Doppler and 2D Speckle-tracking Imaging in Patients with Primary Pulmonary Hypertension

Restrictive Cardiomyopathy

Athletes with cardiac disease; dead and buried or chance for resurrection?

NEW GUIDELINES MAJOR ECHOCARDIOGRAPHIC CRITERIA FOR ARVC MINOR ECHOCARDIOGRAPHIC CRITERIA FOR ARVC

Ref 1. Ref 2. Ref 3. Ref 4. See graph

Historical Notes: Clinical Exercise Testing in the Athlete. An Efficient Heart. Structural Changes, Cont. Coronary Arteries

Echocardiographic Evaluation of the Cardiomyopathies. Stephanie Coulter, MD, FACC, FASE April, 2016

LA Function analysis Marcia Barbosa Vice Presidente - Brazilian Soc of Cardiology President-elect - Interamerican Soc of Cardiology

Value of echocardiography in chronic dyspnea

The importance of left atrium in LV diastolic function

Advanced imaging of the left atrium - strain, CT, 3D, MRI -

HYPERTROPHY: Behind the curtain. V. Yotova St. Radboud Medical University Center, Nijmegen

Echocardiography. Guidelines for Valve and Chamber Quantification. In partnership with

RIGHT VENTRICULAR SIZE AND FUNCTION

The frontier between normal and abnormal electrocardiogram in athletes

EVALUATION OF THE ATHLETE. Karen Stout, MD Professor, Medicine and Pediatrics University of Washington

Cardiac hypertrophy and how it may break an athlete s heart e the Cypriot case

Echo Assessment Pre-TAVI

THE RIGHT VENTRICLE IN PULMONARY HYPERTENSION R. DRAGU

Utility of Echocardiography

Title: Left atrium size in former elite athletes

Screening of Children and Adolescents at Risk of Sudden Cardiac Arrest: What Is the Utility of Non-Invasive Imaging?

Quantitation of right ventricular dimensions and function

Νεότερα ςτην Υπερηχοκαρδιογραφία. Βαςίλειοσ Καμπερίδησ Clinical research fellow in Cardiology

Prognostic Value of Left Atrial Size and Function

Chamber Quantitation Guidelines: What is New?

Training adaptation of the heart according to the static-dynamic components of sports and seasonal changes in the athletes heart

Abnormal ECG patterns and significance in a group of mountaineers

Echocardiography: Guidelines for Valve Quantification

Athletic Cardiac Remodeling in US Professional Basketball Players

Assessing the Impact on the Right Ventricle

Echocardiographic assessment of the right ventricle in paediatric pulmonary hypertension.

Ιπποκράτειες μέρες καρδιολογίας Θεσσαλονίκη, 9-10 Μαρτίου Φωτεινή Α. Λαζαρίδου Επιμελήτρια Α Γενικό Νοσοκομείο Αγιος Παύλος, Θεσσαλονίκη

Diastolic Function: What the Sonographer Needs to Know. Echocardiographic Assessment of Diastolic Function: Basic Concepts 2/8/2012

Rest and Exercise Echocardiography in Hypertrophic Cardiomyopathy: Determinants of Exercise Peak Gradient and Predictors of Outcome

Incorporating the New Echo Guidelines Into Everyday Practice

Dr. Dermot Phelan MB BCh BAO PhD European Society of Cardiology 2012

PRESENTER DISCLOSURE INFORMATION. There are no potential conflicts of interest regarding current presentation

Mædica - a Journal of Clinical Medicine ORIGIN. How to differentiate athlete s heart from pathological cardiac hypertrophy?

An Integrated Approach to Study LV Diastolic Function

Evaluation of the Right Ventricle in Candidates for Right Ventricular Assist Device Implantation.

Left atrial Function In Echocardiography

The Athlete s Heart in Adolescent Africans

Diastolic Function Overview

Strain/Untwisting/Diastolic Suction

Tissue Doppler and Strain Imaging. Steven J. Lester MD, FRCP(C), FACC, FASE

Strain Imaging: Myocardial Mechanics Simplified and Applied

Incidence And Predictors Of Left Bundle Branch Block After Transcatheter Aortic Valve Implantation

Evalua&on)of)Le-)Ventricular)Diastolic) Dysfunc&on)by)Echocardiography:) Role)of)Ejec&on)Frac&on)

Tissue Doppler and Strain Imaging

Sudden Death in Athletes: What is the role of ECG Screening?

DECLARATION OF CONFLICT OF INTEREST. None

Strain imaging in children: from Tissue Doppler to 3 D

LEFT BUNDLE BRANCH BLOCK- BENIGN OR A HARBINGER OF HEART FAILURE? PROGNOSTIC INDICATOR?

Bernhard L. Gerber. Differentiating HCM from athletes heart. Role of contrast enhanced MR.

Quantification of Cardiac Chamber Size

Atrial dyssynchrony syndrome: An overlooked cause of heart failure with normal ejection fraction

Sports Cardiology Highlights from EuroPRevent 2012 Dublin

Echocardiographic Correlates of Pulmonary Artery Systolic Pressure

A new consensus document on electrocardiographic interpretation in athletes: does it help to prevent sudden cardiac death in athletes?

Pediatric Echocardiographic Normal values. SIEC Firenze Febbraio 2016

Transcription:

Echocardiography of the young athlete: Where are the limits? 24 èmes Journées Européennes de la Société Française de cardiologie 15-18 janvier 2014 Sylvain GUERARD LYON-BRON

Déclaration de Relations Professionnelles Disclosure Statement of Financial Interest J'ai actuellement, ou j'ai eu au cours des deux dernières années, une affiliation ou des intérêts financiers ou intérêts de tout ordre avec une société commerciale ou je reçois une rémunération ou des redevances ou des octrois de recherche d'une société commerciale : I currently have, or have had over the last two years, an affiliation or financial interests or interests of any order with a company or I receive compensation or fees or research grants with a commercial company : Affiliation/Financial Relationship Grant/Research Support Consulting Fees/Honoraria Major Stock Shareholder/Equity Royalty Income Ownership/Founder Intellectual Property Rights Other Financial Benefit Company Company One Company Two Company Three Company Four Company Five Company Six Company Seven

You said athlete? Training 6-8h/week; > 6 month; > 60% VO2 max No symptom and powerful VO2 > 150% Fagard R. Heart 2003

Athlete s Heart Pluim BM et al, Circulation, 2000, 101 : 336-44 Urhausen A et Kinderman W, Sports Med, 1999, 28(4) : 237-244 LEFT VENTRICULAR DILATATION LVWT : +2 to 3 mm LVED: +3 to 6 mm LEFT VENTRICULAR HYPERTROPHY

LVED > 60 mm? 442 athletes, 13 sports 5.8% > 60 mm (max 65 mm) in males 0 % > 60 mm in females Whyle GP Eur. J. App. Physiol. 2004;92:592 1309 athletes 38 sports LVEDD 55 mm (43-70) males vs 48 mm (38-66) females 14% > 60 mm Pelliccia Ann Intern Med 1999;130: 3 Ultrarunners (100kms) 291 athlètes : LVEDD 61,8 ± 6,9 mm LVEDD > 70 mm: 11% Nagashima JACC 2003;42:1617 900 adolescent athletes 15,7 years (14-18) LVED 50,8 mm vs 47,9 LVEDDi 29,3 mm/m2 vs 28,3 18% 55 mm Mc KENNA Heart 2005;91:495 LVEDD index mm/m2 BSA Teenagers: 29-30, Males: 31-32, and Females: 32-33 mm/m2

Distribution of LVWT in athletes: 3500 Highly trained british athletes LVWT > 12mm in 1.5% Maximal value 16 mm Basavarajaiah S J Am Coll Cardiol 2008;51:1033-9 Our personal serie 200 athletes LVWT : 9.5 ± 1.5 No > 13 mm 1232 elite athletes 357 females 875 males Kervio G et al. 2008

Distribution of LVWT in athletes: the female athletes 240 nationally ranked black athletes and 200 white athletes 21 ± 4,6 years LVWT : 9,2±1,2 vs 8,6±1,2 mm (p<0.001) Only 8 black female athletes (3%) > 11mm None white > 11mm Rawlins J Circulation 2010;121:1078-1085 1000 Italian female athletes LVWT maxi :12 mm Pelliccia A, Maron BJ et al. J Am Med Assoc 1996;276:211-5

Left Ventricular Hypertrophy in black athletes 300 Black athletes vs 300 White athletes 18% Basavarajaiah S J Am Coll Cardiol 2008;51:2256-62 3% Papadakis M Br.J.Sports Medecine 2012

Distribution of LVWT in athletes: the junior elite athletes 720 junior elite athletes vs 250 teenager 15,7 ± 1,4 years LVWT : 9,5±1,7 vs 8,4±1,4 3 males (0.4%) > 12 mm > 16 years No female > 11mm Sharma S JACC 2002;40:1431-6 107 teenagers top-level athletes 12-16 years 66 males + 41 females LVWT 8,1±1,2 mm (6-11 mm) Griffet V. Ann Card Angeiol 2013; 62: 116-121

Athlete s Heart or HCM Male athlete 15 mm white 16 mm black Female athlete 11 mm white 13 mm black teenager (12-18) 11 mm female 12 mm male Impact of extreme anthropometry +++ Riding NR B.Jr.Sports medecine 2012

Effectif Left ventricular diastolic function Hypernormal function 35 athletes (22 years) long distance competitive swimmer Ea (cm/s): 28 +/- 6 vs 16 +/- 4 cm/s Pio Caso et al.: Am J Cardiol 2002 18 highly trained rowing athletes (20,7 years) Ea (cm/s): 19,2 +/-3,8 vs 14,8 +/-3,5 cm/s S.Zoncu et al. J Am Soc Echocardiogr 2002 Distribution des valeurs de Ea 40 35 75% 30 25 20 94% 15 10 5 e : 18.6 ± 3.0 cm/s E/e : 5.2 ± 1.0 0 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 Valeurs de Ea Griffet V Arch Mal Cœur Vaiss 2007;100(10):809-15

e /a and s mitral (pulsed DTI) 650 athletes 350 endurance athletes (ATE) 280 power athletes (ATP) e and a inferospetal and anterolateral sites e /a > 1 (both sites) in 100% e 16±5 cm/s (anterolateral) 14±3 cm/s (inferoseptal) e a D Andrea A. JASE 2010;23:1281 100 handball players infero-septal and antero-lateral sites e : 16,6±3,4 cm/s (anterolateral) 13,2±2,8 cm/s (inferolateral) none with s <9 cm/s and e <9 cm/s at any sites of the mitral annulus Butz T EJCVPR 2010;17:342 Pathological LV hypertrophy e (inferior or latéral) < 16 cm/s Se=100% Sp=95% s moyen (4 sites) < 9 cm/s Se=73% Sp=97% s

Is it enough?

2D strain: speckle tracking Regional and global longitudinal strain 20 athletes, 15 HCM and 18 controls GLS -15,2% vs -8,1% vs -16,0% Cut off -10% Se 86% Sp 95% Combination of DTI (s +e/2 ) and 2DS (GLS) cut off values Se=100% Sp=95% BUTZ Th Int.J Cardiovasc Imaging 2010;27:91-100 650 athletes (280 ATP and 370 ATE) LV GLS -17% overall, -17,2% ATP, -18,1% ATE 90% of athletes: GLS -16% s 10 cm/s, e 16 cm/s D Andrea A. JASE 2010;23:1281

Rugbyman: IVWT 13 mm, e = 9,55 cm/s, GLS= -14% 45 bodybuilders vs controls IVWT (mm) 2DS (GLS%) 25 steroids + 12,3-15 ± 5 20 steroids - 11,2-20 ± 6 25 controls 9,3-19 ± 6 D Andréa Br. J. Sport Méd.

Trabeculations or LV non compaction 1146 athletes (14-35 yrs ) vs 415 controls 63.3% males Higher prevalence of increased LV trabeculation 18.3% vs 7% 8.1% fulfilled conventional criteria of LVNC Location Apical in LV non compaction (68% vs 47%) Infero-septal in athlète (53% vs 27%) 10 (0.9%) : reduced systolic function, marked repolarisation changes No reveal adverse in follow-up during 48 month Gati S. Heart 2013

Aortic root dilatation in athletic population Pellicia A circulation 2010;122:698-706 Remodeling of the aortic root 2317 athletes 24,8±6,1 years 56% males 32,2 mm (males) vs 27,5 mm (females) 99th percentile value: 40 mm in males 34 mm in females cycling water polo swimming basketball

Left atrial volume index in highly trained athletes Diamètre TM de l OG: > 40 mm dans 17 à 20% Kervio G. et coll 2008 Pellicia A. JACC 2005 615 athletes: 370 ATE + 245 ATS (28,4±10,2 years) LA vol. index: 27,8±9,3 ml/m 2 LA diameter 34,4±5,5 mm Males: 26-36 ml/m2 vs Females: 22-33 ml/m 2 29-33 ml/m2 Independent predictors: >34ml/m2 Type and duration of training LVED volume D Andrea A. Am Heart J 2010;159:1155-61

Determinants of echocardiographic left atrial 418 healthy individuals, 41,7±15,6 years 157 competitives athletes (38%), LA vol.index : 32.2±9 ml/m2 38.9 ± 9.6 vs 28.4 ± 5.8 ml/m2 28,4±5,8 ml/m2 38,9±9,6 ml/m2 Determinants: LVEDV index LVmass index Competitive sports Age NISTRI S. Eur J Echocardiogr. 2011;12:826-833

Range of right heart measurements in top-level athletes D Andréa A. International Journal of cardiology 2013;164:48-57 650 top-level athlètes, 395 (ATE), 255 (ATS) vs 230 controls 28,4 ±10,1 years, 63% males RV and RA in ATE % ATS and controls early diastolic RV function whereas RV systolic index were comparable

RV morphology and function 430 athletes (210 STA et 220 ETA) vs 250 controls 27,4 years, 61,7% males RV 2D 3D diameter volume PAPs D Andréa A. JASE 2012;25:1268-76 RV systolic indexes # - TAPSE - DTI RV peak systolic velocity

RV in athletes or ARVC? Oxborough D JASE 2012 28% of 102 athlètes : RV outflow tract values > major criteria of ARVC RV scalled to BSA Normal Systolic Index 40% > 35 mm 57%> 42 mm Ratio RV/LV < 1,17 Speckle tracking > -15%

When suspected pathology? LV end diastolic diameter > 65 mm > 30 mm/m 2 adolescents> 31 mm/m 2 males or > 32 mm/m 2 females LVWT > 13 mm in males, 12 mm in females, 11 mm in adolescents Diastolic dysfunction E<A, e, e /a, s Aortic root diameter > 40 mm in males or > 34 mm in females LA vol. index 33 ml/m 2 Training < 8 h/week VO2 max < 110-130%